Cancer of the Larynx Clinical Trial
Official title:
Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life
Swallowing and speech difficulties will be observed in patients post laryngectomy. These difficulties will cause decreased in quality of life.
This study will explore the characteristics of speech and swallowing problems of patients who underwent laryngectomy.The relationship between swallowing disturbances and speech difficulties will be studied and the effect of each problem on quality of life will be messured. ;
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00117572 -
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
|
Phase 3 | |
| Recruiting |
NCT00970502 -
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT00462735 -
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT00593840 -
Phase II Trial Evaluating Elimination of Radiation Therapy
|
Phase 2 |